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Objective: To determine the inhibition activity of Typhonium ﬂagelliforme Lodd. Blume
(T. ﬂagelliforme) leaf extract on cyclooxygenase 2 (COX-2) expression of colon cancer
cells.
Methods: T. ﬂagelliforme leaf extract was prepared to macerate in ethyl acetate. In vitro
anticancer activity was assayed by MTT method on WiDr colon cancer cells. This study
applied apoptosis induction assay to investigate the mechanism of cell death using double
staining method. COX-2 expression was stained by immunocytochemistry.
Results: T. ﬂagelliforme showed anticancer activity and induced apoptosis on WiDr cells
through inhibition of COX-2 expression with IC50 70 mg/mL.
Conclusions: This study showed that T. ﬂagelliforme is a promising chemopreventive
agent for colon cancer through COX-2 inhibition.1. Introduction
Colon cancer is one of the leading causes of cancer related
death in developed countries, and it is a frequently diagnosed
cancer in both of male and female [1]. It was also ranked as the
third most commonly diagnosed cancer worldwide, especially in
the Southeast Asian Nations [2,3]. Colon cancer is known as a
disease in industrialized countries, but the pattern is
economically changing nowadays. Since its incidence rapidly
increases [4,5], many attempts are employed to prevent and
cure colon cancer. There are many possible clinical
managements of colon cancer treatment, such as surgery,
chemotherapy, radiotherapy and adjuvant chemotherapy [5,6].
Many studies had been designed to develop colon cancer
treatment by attacking speciﬁc targets which is a key strategy
to cure colon cancer without endangering normal cells [7–9].Colon cancer overexpresses cyclooxygenase 2 (COX-2) in
both carcinoma and adenoma [10–12]. COX-2, an enzyme that is
responsible for converting arachidonic acid to prostaglandins
[13], plays an important role in cell proliferation and apoptosis
regulation of colon cancer [14]. Prostaglandin E2, a type of
COX-2 product, promotes angiogenesis and stimulates colon
cancer growth by preventing apoptosis [15,16]. Thus, COX-2
inhibitors had shown to successfully prevent colon cancer
growth and polyp formation [16–21]. Moreover, COX-2 is a
speciﬁc molecular target for anticancer screenings on colon
cancer.
Many studies investigated a natural product activity on colon
cancer [22–25], especially addressing COX-2 as molecular target
[10,25]. Curcumin, a yellow pigment isolated from turmeric,
successfully inhibited COX-2 on WiDr colon cancer cells [21].
Another promising natural product which potentially exhibits
anticancer activity on colon cancer is Typhonium ﬂagelliforme
Lodd. Blume (T. ﬂagelliforme). Its leaves contain glycoside
ﬂavonoid, isovitexin, as well as alkaloids [26,27]. Previous
studies showed that T. ﬂagelliforme revealed cytotoxic activity
on MCF-7 breast cancer cells [28], and induced apoptosis on
murine leukemia WEHI-3 cells [29] and lymphocyte CEM-SS
[30]. However, the cytotoxic activity of T. ﬂagelliforme on
colon cancer cells with COX-2 as the molecular target remains
delusive. Therefore, this study investigated cytotoxic activity ofarticle under the CC BY-NC-ND license (http://
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highly express COX-2.
2. Materials and methods
2.1. Plant materials
The leaves of T. ﬂagelliforme were harvested from Malang
(East Java, Indonesia) in June 2014, and sun-dried after thor-
ough washing. The plant materials were identiﬁed in Department
of Pharmaceutical Biology, Faculty of Pharmacy, Universitas
Gadjah Mada (Reference No. BF/275/Ident/Det/VI/2014).
2.2. Cytotoxic, apoptosis and immunocytochemistry
assay materials
WiDr cells were collected from Parasitology Department,
Faculty of Medicine, Universitas Gadjah Mada. The cells were
maintained in Roswell Park Memorial Institute medium (Gibco)
containing fetal bovine serum 10% (v/v) (Gibco) and penicillin-
streptomycin 1% (v/v) (Gibco). Dimethyl sulfoxide was used to
dissolve stock solution of extract and celecoxib was purchased
from Merck. Celecoxib, as a positive control, was prepared from
Celebrex®. Cytotoxic assay was measured by MTT (Sigma)
method, while the apoptosis assay was examined by ethidium
bromide and acridine orange (Sigma) staining. Immunocyto-
chemistry used COX-2 primary antibody purchased from
Thermo Scientiﬁc Lab Vision, while the universal secondary
antibody was derived from Starr Trek Universal HRP Detection
System No.901-STUHRP700-090314. All culture plates used in
this study were Iwaki® and all tips and microtubes were supplied
by Biologix®.
2.3. Extract preparation
The extract was prepared by using maceration method. Dried
leaves of T. ﬂagelliforme were ground and soaked in ethyl ac-
etate (1:10) for 24 h until all substances were extracted. The
liquid extract was slowly evaporated to discard the residual
solvent, until viscous extract was obtained.
2.4. MTT cytotoxic assay
Cytotoxic assay was designed based on several previous
studies [31–33]. WiDr colon cancer cells were cultured in culture
tissue ﬂask until 70%–80% conﬂuent, and then 5 × 103 cells
were seeded into 96-well plate. The plate was incubated at
37 C and under 5% CO2 for 24 h. The medium was removed
and the cells were rinsed twice by using phosphate buffer so-
lution (PBS). The stock solution of extract and celecoxib were
prepared to dissolve them into dimethyl sulfoxide and dilute
them with the medium into various concentrations. Each con-
centration (100 mL/well) was added into 96-well plate and
measured in triplicates. Later, the plate was incubated at 37 C
and under 5% CO2 for 24 h. The medium was then removed and
10% MTT containing medium was added into each well. The
reaction between MTT and succinate hydrogenase of cells to
form formazan needed 4 h. At the end of incubation time,
100 mL sodium dodecyl sulfate was added to each well todissolve formazan crystals. The plate was incubated in dark
room for 12–24 h and formazan crystals were measured by using
ELISA reader at a wavelength of 595 nm.
2.5. Apoptosis induction assay
WiDr cells were cultured into coverslips in 24-well plate
(5 × 104/well). The cells were adapted at 37 C and 5% CO2 for
24 h. The medium was removed and rinsed twice by using PBS.
The extract (100 mg/mL) and celecoxib at IC50 concentration
(68 mmol/L) were added into the plate and incubated in the same
condition as previously described. The medium was removed
from the cells and rinsed by using PBS. The coverslips were
transferred to object glasses, then acridine orange/ethidium
bromide was dropped into the coverslips. The cells were
immediately observed under ﬂuorescence microscope.
2.6. Immunocytochemistry assay
WiDr cells were seeded in 6-well plate and incubated under
5% CO2 and 37

C for 24 h. The extract at 100 mg/mL and
celecoxib at IC50 68 mmol/L were added to the cells and incu-
bated for further 24 h. At the end of incubation time, cells were
harvested and washed by PBS. The cells were suspended in
medium, placed and ﬁxed in object glass for 5 min. Hydrogen
peroxidase was dropped into the object glass and incubated at
room temperature for 10–15 min. The cells were washed twice
with PBS and monoclonal antibody of COX-2 was added into
the cells and incubated at least for 1 h at room temperature. The
cells were washed three times with PBS and added with sec-
ondary antibody, incubated at room temperature for 10 min, and
washed four times with PBS. The solution of 3,30-dia-
minobenzidine, as chromogen, was added to the cells and
incubated for 3–8 min. Finally, the cells were washed with
distilled water and added with hematoxylin solution followed by
3–4 min incubation. The expression of COX-2 was observed
under inverted microscope.
2.7. Data analysis
Cell viability was calculated from MTT data using equation:
Sample treatment absorbance − Medium absorbance
Untreated cells absorbance − Medium absorbance
× 100%
Cell viability data were analyzed by using linear regressions
at four linier points to calculate IC50 of extract and celecoxib.
Apoptosis induction semiquantitatively counted the number of
apoptotic, necrotic and living cells in three different areas of an
object glass. Each treatment was performed in triplicate. The
number of COX-2 expressing cells was analyzed by t-test using
Microsoft Excel 2013.
3. Results
This study investigated the cytotoxic effect of T. ﬂagelliforme
leaf extract on WiDr colon cancer cells by targeting COX-2.
Celecoxib, a selective COX-2 inhibitor, was used as a positive
control. Dixon et al. reported celecoxib was a prospective
anticancer on colon cancer [10]. Cytotoxic effect, assessed with
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595 nm that equaled to the number of living cells. As presented
in Figures 1 and 2, T. ﬂagelliforme leaf extract (R2 = 0.995) and
celecoxib (R2 = 0.954) showed dose dependent cytotoxic ac-
tivity on WiDr colon cancer cells with IC50 70 mg/mL and
68 mmol/L, respectively.Figure 2. Effect of celecoxib in various concentrations on WiDr cells
viability.
Figure 3. The observation of apoptotic cells on double staining method
under ﬂuorescence microscope using 400× magniﬁcation.
A: Untreated cells; B: Cells treated 100 mg/mL T. ﬂagelliforme leaf extract;
C: Cells treated 68 mmol/L celecoxib; White arrow: Living cell; Yellow
arrow: Early apoptotic cell; Red arrow: Late apoptotic cell.
Figure 4. The observation of COX-2 expression cells on immunocyto-
chemistry method under light microscope using 400× magniﬁcation.
A: Untreated cells; B: Cells treated 100 mg/mL T. ﬂagelliforme leaf extract;
C: Cells treated 68 mmol/L celecoxib; Brown color: COX-2 expression.
Table 2
Number of cells that expressed COX-2.
Treatment Mean ± SD
Untreated cells 69.36 ± 10.20
Extract 39.22 ± 3.63a
Celecoxib 14.32 ± 1.24a
a: Referred to signiﬁcant difference to untreated cells (P < 0.05).
Figure 1. Effect of T. ﬂagelliforme leaf extract in various concentrations on
WiDr cells viability.Double staining method was employed to determine the
mechanism of cells death. T. ﬂagelliforme leaf extract induced
apoptosis [(65.27 ± 1.27)%] on WiDr cells as well as celecoxib
[(88.67 ± 1.23)%] (Table 1). This method also successfully
identiﬁed apoptosis stage and resulted in insigniﬁcant difference
to ﬂow cytometry method [34]. In early apoptotic cells, the nuclei
showed condensed yellow-green ﬂuorescence by acridine or-
ange. On the other hand, the nuclei of late apoptotic cells
showed condensed orange ﬂuorescence by ethidium bromide
(Figure 3).
Molecular mechanism of T. ﬂagelliforme leaf extract was
speciﬁcally observed by immunocytochemistry method. COX-2
expressing cells showed brown color while non-expressing cells
showed purple color (Figure 4). WiDr cells were stained asTable 1
Cell distribution after double staining. %.
Treatment Apoptosis Necrosis Living
TLE 65.27 ± 1.27 14.16 ± 0.48 20.94 ± 1.42
Celecoxib 88.67 ± 1.23 2.23 ± 2.59 9.10 ± 0.00
Untreated cells 1.08 ± 0.00 0.00 ± 0.00 98.90 ± 0.00
Data were expressed as mean ± SD. TEL: T. ﬂagelliforme leaf extract.intense brown color, but T. ﬂagelliforme leaf extract and cele-
coxib treated cells were stained as purple color. This result
indicated that WiDr highly expressed COX-2 but
T. ﬂagelliforme leaf extract and celecoxib inhibited COX-2
expression. Semi-quantitative analysis of this result conﬁrmed
that T. ﬂagelliforme leaf extract and celecoxib signiﬁcantly
suppressed COX-2 expression on WiDr cells (P < 0.05)
(Table 2). This data suggested that cytotoxic activity of
T. ﬂagelliforme leaf extract on WiDr cells was through COX-2
downregulation.4. Discussion
This study evaluated the anticancer activity of
T. ﬂagelliforme leaf extract on WiDr colon cancer cells through
COX-2 expression. COX-2 produced prostaglandin E2 that
increased proliferation and prevented cells from apoptosis [14,15].
Addressing COX-2 is an effective strategy to screen chemo-
preventive agents on colon cancer.
Our results concluded that T. ﬂagelliforme leaf extract, as
well as celecoxib, performed anticancer activity on WiDr cells
by inhibiting COX-2 expression. These results have also opened
interesting question on whether the inhibition of COX-2
expression of T. ﬂagelliforme leaf extract was possible due to
the presence of antioxidant compounds. It is well known that the
colon is prone to oxidative condition and antioxidant deﬁciency
[35]. Under oxidative stress, COX-2 was highly produced to
modulate inﬂammation and induce carcinogenesis [36]. Pro-
oxidant stress factor such as cigarette smoking, a diet high in
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increase genotoxic damage of intestine [37].
On the other hand, the presence of antioxidant suppresses
reactive oxygen species (ROS) formation and inhibits cancer cell
proliferation [38,39]. A study by La Vecchia et al. showed an
inverse correlation between antioxidant intakes and the risk of
colorectal cancer [40]. Another study reported that low
antioxidant status could support cancer development and
therefore antioxidant supplement may be beneﬁcial for cancer
patient [41].
Isovitexin, isolated compound from ethyl acetate extract of
T. ﬂagelliforme leaves [26], showed antioxidant activity
protecting cells from ROS [42]. This compound was reported
to be responsible for the cytotoxic activity and COX-2 inhibi-
tion activity of T. ﬂagelliforme leaf extract on WiDr cells.
Previous studies established that antioxidants reduced the risk
of colorectal cancer by COX-2 downregulation [43,44].
However, the mechanism of anticancer activity through
antioxidant activity still needs to be further investigated since
the role of ROS on carcinogenesis has dual role in either
induction or inhibition of carcinogenesis [40,45].
Carcinogenesis can be induced by ROS formation in higher
concentration, while ROS could also be possible to induce
apoptosis on cells [40,46].
To conclude, T. ﬂagelliforme leaf extract offers a new
promising chemopreventive agent on colon cancer. Our data
showed that T. ﬂagelliforme leaf extract inhibits COX-2
expression. Nevertheless, details on molecular mechanism of
these beneﬁts remain to be established in the future study.
Anticancer activity of T. ﬂagelliforme leaf extract and cele-
coxib on WiDr colon cancer cells was mediated by COX-2 in-
hibition, however the molecular mechanism needs to be further
investigated.
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